These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11260085)

  • 1. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
    Bolan CD; Childs RW; Procter JL; Barrett AJ; Leitman SF
    Br J Haematol; 2001 Mar; 112(3):787-95. PubMed ID: 11260085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
    Worel N; Greinix HT; Keil F; Mitterbauer M; Lechner K; Fischer G; Mayr W; Höcker P; Kalhs P
    Transfusion; 2002 Oct; 42(10):1293-301. PubMed ID: 12423513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor.
    Kanda Y; Tanosaki R; Nakai K; Saito T; Ohnishi M; Niiya H; Chizuka A; Yakushijin K; Urahama N; Ueda K; Iijima K; Ando T; Matsubara H; Kami M; Makimoto A; Kobayashi Y; Tobinai K; Mineishi S; Takaue Y
    Br J Haematol; 2002 Jul; 118(1):128-31. PubMed ID: 12100136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility.
    Laurencet FM; Samii K; Bressoud A; Tajeddin M; Easton J; Stelling MJ; Chapuis B
    Hematol Cell Ther; 1997 Jun; 39(3):159-62. PubMed ID: 9262993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
    Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
    Maciej Zaucha J; Mielcarek M; Takatu A; Little MT; Gooley T; Baker J; Maloney DG; Sandmaier BM; Maris M; Chauncey T; Storb R; Torok-Storb B
    Br J Haematol; 2002 Dec; 119(3):740-50. PubMed ID: 12437653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant.
    Tiplady CW; Fitzgerald JM; Jackson GH; Conn JS; Proctor SJ
    Transfus Med; 2001 Dec; 11(6):455-8. PubMed ID: 11851944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.
    Marenchino D; Maddalena L; Balbo R; Avonto I; Menardi G; Prucca M; Perotti L; Mordini N; Peano G
    Blood Transfus; 2011 Jan; 9(1):79-85. PubMed ID: 21084015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
    Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
    Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
    Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility.
    Noborio K; Muroi K; Izumi T; Toshima M; Kawano-Yamamoto C; Otsuki T; Nagai T; Komatsu N; Ozawa K
    Leuk Lymphoma; 2003 Feb; 44(2):357-9. PubMed ID: 12688358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
    Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
    Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ABO-incompatible nonmyeloablative allogeneic peripheral blood stem cell transplantation].
    Sun WJ; Guo M; Qiao JH; Yu CL; Wang DH; Sun QY; Zhang S; Li X; Ai HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):39-42. PubMed ID: 15748433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.
    Lee JH; Lee JH; Choi SJ; Kim S; Seol M; Kwon SW; Park CJ; Chi HS; Lee JS; Kim WK; Lee KH
    Br J Haematol; 2003 Feb; 120(4):702-10. PubMed ID: 12588361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.